These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Endovascular brachytherapy in coronary arteries: the Rotterdam experience. Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062 [TBL] [Abstract][Full Text] [Related]
7. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization. Sheppard R; Eisenberg MJ; Donath D; Meerkin D Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925 [TBL] [Abstract][Full Text] [Related]
8. Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosis. Carter AJ; Jenkins S; Sweet W; Bailey L; Jones R; Fischell TA; Virmani R Cardiovasc Radiat Med; 1999; 1(4):327-35. PubMed ID: 10828562 [TBL] [Abstract][Full Text] [Related]
9. Experimental results with endovascular irradiation via a radioactive stent. Carter AJ; Laird JR Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):797-803. PubMed ID: 8960505 [TBL] [Abstract][Full Text] [Related]
10. Update on radiation for restenosis. French MH; Faxon DP Rev Cardiovasc Med; 2002; 3(1):1-6. PubMed ID: 12439348 [TBL] [Abstract][Full Text] [Related]
11. Response to radiation therapy in animal restenosis models. Waksman R Semin Interv Cardiol; 1997 Jun; 2(2):95-101. PubMed ID: 9546998 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions. Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548 [TBL] [Abstract][Full Text] [Related]
13. Pure beta-particle-emitting stents inhibit neointima formation in rabbits. Hehrlein C; Stintz M; Kinscherf R; Schlösser K; Huttel E; Friedrich L; Fehsenfeld P; Kübler W Circulation; 1996 Feb; 93(4):641-5. PubMed ID: 8640989 [TBL] [Abstract][Full Text] [Related]
14. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience. Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747 [TBL] [Abstract][Full Text] [Related]
15. Effect of stent on radiation dosimetry in an in-stent restenosis model. Fan P; Chiu-Tsao ST; Patel NS; Shih A; Ravi K; Sherman W; Tsao HS; Pisch J; Harrison LB Cardiovasc Radiat Med; 2000; 2(1):18-25. PubMed ID: 11229057 [TBL] [Abstract][Full Text] [Related]
16. Feasibility and safety of beta irradiation in human coronary arteries. Urban P; Verin V; Popowski Y; Rutishauser W Semin Interv Cardiol; 1997 Jun; 2(2):125-31. PubMed ID: 9546993 [TBL] [Abstract][Full Text] [Related]
18. Improving patient-specific dosimetry for intravascular brachytherapy. Li XA; O'Neill M; Suntharalingam M Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260 [TBL] [Abstract][Full Text] [Related]
19. Current status of radioactive stents for the prevention of in-stent restenosis. Carter AJ; Fischell TA Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):127-33. PubMed ID: 9588927 [TBL] [Abstract][Full Text] [Related]
20. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents. Grube E; Buellesfeld L Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]